Full Text
Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?

Abstract

Authors

Sreeram V. Ramagopalan

Back to Volume 28, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×